Medicus Pharma Ltd. — Director's Dealing 2025

Jul 31, 2025

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Medicus Pharma Ltd. (MDCX)
CIK: 0001997296
Period of Report: 2025-07-22

Reporting Person: Rodgers Cathy McMorris (Director)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$3.08	2030-07-22	Common Shares (25000)		Direct

Footnotes

F1: The option was granted on July 22, 2025. The option is scheduled to vest quarterly in four equal installments over one year.